Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126219411 | 12621941 | 1 | I | 20160727 | 20160804 | 20160804 | EXP | FR-PFIZER INC-2016363861 | PFIZER | 47.00 | YR | F | Y | 0.00000 | 20160804 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126219411 | 12621941 | 1 | PS | XANAX | ALPRAZOLAM | 1 | 0.75 MG, DAILY | U | 18276 | .75 | MG | TABLET | |||||||
| 126219411 | 12621941 | 2 | SS | TERCIAN | CYAMEMAZINE | 1 | 25 MG, 2X/DAY | U | 0 | 25 | MG | TABLET | BID | ||||||
| 126219411 | 12621941 | 3 | SS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | 10 MG, DAILY | U | 0 | 10 | MG | ||||||||
| 126219411 | 12621941 | 4 | SS | HEROIN | DIACETYLMORPHINE | 1 | UNK | U | 0 | ||||||||||
| 126219411 | 12621941 | 5 | C | DAFALGAN CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | 1000 MG, 3X/DAY | 0 | 1000 | MG | TABLET | TID |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126219411 | 12621941 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126219411 | 12621941 | Drug abuser | |
| 126219411 | 12621941 | Drug dependence | |
| 126219411 | 12621941 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |